mortality/aging
• notice sudden death of heterozygotes older than 18 months of age, probably as a result of the rupture of huge hepatic hemangiomas
|
neoplasm
• most tumors that develop exhibit loss of heterozygosity (LOH)
|
• tumors in extremities develop with a high frequency
|
• transplacental administration of ENU accelerates renal tumorigenesis compared to controls
|
• detect leiomyoma/leiomyosarcoma in the uterus
|
• detect leiomyoma/leiomyosarcoma in the uterus
|
• mutants develop macroscopically visible renal carcinomas and/or renal cystadenomas by 10 months of age
|
• detect hemangioma in the tail
|
• about 80% of mutants develop hepatic hemangiomas by 15-18 months of age
|
• mutants develop macroscopically visible renal carcinomas and/or renal cystadenomas by 10 months of age
|
homeostasis/metabolism
• transplacental administration of ENU accelerates renal tumorigenesis compared to controls
|
renal/urinary system
• mutants develop macroscopically visible renal carcinomas and/or renal cystadenomas by 10 months of age
|
• mutants develop macroscopically visible renal carcinomas and/or renal cystadenomas by 10 months of age
|
muscle
• detect leiomyoma/leiomyosarcoma in the uterus
|
• detect leiomyoma/leiomyosarcoma in the uterus
|
liver/biliary system
• about 80% of mutants develop hepatic hemangiomas by 15-18 months of age
|
reproductive system
• detect leiomyoma/leiomyosarcoma in the uterus
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
tuberous sclerosis | DOID:13515 |
OMIM:PS191100 |
J:70463 |